Induction of a cytotoxic T-cell response to HIV-1 proteins with short synthetic peptides and human compatible adjuvants

By Peter K.   Men Y.   Pantaleo G.   Gander B.   Corradin G.  

Vaccine, Vol. 19, Iss. 30, 2001-07 ,pp. : 4121-4129

Elsevier

Access to resources Recommend Favorite

Induction of neutralizing antibody and T-cell responses to Varicella-zoster virus (VZV) using Ty-virus-like particles carrying fragments of glycoprotein E (gE)

By Garcia-Valcarcel M.   Fowler W.J.   Harper D.R.   Jeffries D.J.   Layton G.T.  

Vaccine, Vol. 15, Iss. 6, 1997-04 ,pp. : 709-719

Elsevier

Access to resources Recommend Favorite

Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugate cancer vaccines

By Kim S.K.   Ragupathi G.   Musselli C.   Choi S.-J.   Park Y.S.   Livingston P.O.  

Vaccine, Vol. 18, Iss. 7, 1999-11 ,pp. : 597-603

Elsevier

Access to resources Recommend Favorite

B- and T-cell responses to the mycobacterium surface antigen PstS-1 in the respiratory tract and adjacent tissues - Role of adjuvants and routes of immunization

By Rodrguez A.   Troye-Blomberg M.   Lindroth K.   Ivanyi J.   Singh M.   Fernandez C.  

Vaccine, Vol. 21, Iss. 5, 2003-01 ,pp. : 458-467

Elsevier

Access to resources Recommend Favorite

Induction of T 1 (cytotoxic lymphocyte) and/or T 2 (antibody) responses to a mucin-1 tumour antigen

By Lofthouse S.A.   Apostolopoulos V.   Pietersz G.A.   Wenjun L.   McKenzie I.F.C.  

Vaccine, Vol. 15, Iss. 14, 1997-10 ,pp. : 1586-1593

Elsevier

Access to resources Recommend Favorite